|
|
|
|
alanosine
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called antimetabolites. Also called SDX-102. (National Cancer Institute)
[an error occurred while processing this directive]
Additional Resources on alanosine from the National Cancer Institute
Cancer.gov Phase II Study of Alanosine in Patients With Methylthioadenosine Phosphorylase (MTAP)-Deficient
Cancer. Date First Published: 2003-05-23. BASIC STUDY INFORMATION. ...
Cancer.gov Phase I/II Study of Alanosine (SDX-102) in Patients With Methylthioadenosine Phosphorylase
(MTAP)-Deficient High-Grade Progressive or Recurrent Malignant ...
NSC, Agent Name "723227","(161-180)ESO-1" "726584","(H115D)VHL35" ... KNI-272" "674781","KRAS CYS-12 MUTANT PROTEIN" "650426","KRN5500" "710270","Karenitecin"
"713762","Keyhole Limpet Hemocyanin" "153353","L-ALANOSINE" "529469","L ...
Center for Cancer Research - Staff Pages 81) Jayaram HN, Tyagi AK, Anandaraj S, Montgomery JA, Kelley JA, Kelley J, Adamson
RH, Cooney DA: Metabolites of alanosine, an antitumor antibiotic. ...
|
|
|